A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane
Clinical trial NCT03003078 · COMPLETED
Trial details
- NCT number
- NCT03003078
- Sponsor
- OncoSil Medical Limited
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-27
- Primary completion
- 2020-07-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.